ARTICLE | Clinical News
Intermezzo zolpidem regulatory update
November 2, 2009 8:00 AM UTC
FDA issued a complete response letter to Transcept for Intermezzo zolpidem to treat insomnia when a middle of the night awakening is followed by difficulty returning to sleep. In the letter, FDA reque...